Phase 1 Malaria infection Clinical Trials
5 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–5 of 5 trials
Completed
Phase 1
Safety of Plasmodium falciparum K13 isolate in healthy participants.
Malaria infection
QIMR Berghofer Medical Research Institute2 enrolled1 locationACTRN12617000244303
Completed
Phase 1
Blood stage challenge study to assess Tafenoquine prophlyaxis against Plasmodium falciparum in healthy volunteers.
Malaria infection
60 Degrees Pharmaceuticals Australia (60P) Pty Ltd16 enrolled1 locationACTRN12617000102370
Completed
Phase 1
Blood stage pilot challenge study to assess the safety and the infectivity of Plasmodium malariae isolate (HMPBS-Pm) in healthy volunteers
Malaria infection with P. malariae strain
QIMR Berghofer Medical Research Institute2 enrolled1 locationACTRN12617000048381
Completed
Phase 1
Chloroquine effects on Plasmodium vivax isolate HMPBS02-Pv
Malaria infection
QIMR Berghofer Medical Research Institute24 enrolled1 locationACTRN12616000174482
Completed
Phase 1
An experimental study to characterize the in vivo safety and infectivity of the Plasmodium vivax isolate HMPBS02-Pv in humans
Experimental malaria infection
QIMR Berghofer Medical Research Institute2 enrolled1 locationACTRN12614000930684